Lead Product(s): PD01
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Phase I Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 27, 2020
In its written response, the FDA addressed AFFiRiS' questions and provided guidance on the design of the planned phase 2 trial.